Noumi Limited (ASX:NOU) is a leading Australian producer of plant-based and dairy milks, nutritional products, and ingredients, operating brands including Milklab and Freedom Foods. The company serves the HORECA (hotel/restaurant/café), retail, and international markets, and has been executing a multi-year Business recovery following earlier financial difficulties.

Recent Development

On 20 August 2026, Noumi reported its FY26 financial results, with Group net Revenue rising 8.8% to $648.4 million. Plant-based Milks revenue grew 2.4% while Dairy & Nutritionals revenue increased 11.6%. Group adjusted operating EBITDA rose 7.6% to $61.8 million. Dairy & Nutritionals delivered a particularly strong result, with adjusted operating EBITDA nearly doubling — up 94.1% from $11.1 million to $21.6 million — driven by strong returns from bulk cream amid favourable Commodity prices. Plant-based Milks delivered adjusted operating EBITDA of $43.1 million, down 14.2%, reflecting deliberate Brand and Marketing investment. The statutory net loss after tax was $67.2 million, which includes non-cash convertible notes Fair Value adjustments; without this item, Noumi noted that net Earnings would again have been positive. Cash at bank and undrawn facilities of $25.3 million provide sufficient Liquidity for near-term operations, though Noumi flagged the requirement to refinance its Revolving Finance Facility and convertible notes.

Sector Context

The Australian and international plant-based milk market has experienced growth moderation after a period of rapid expansion, with competitive intensity increasing from both dedicated plant-based brands and dairy incumbents launching their own alternatives. Noumi's Milklab brand has established strong positioning in the HORECA channel — particularly in café settings — but faces Volume headwinds as economic conditions have tightened consumer and hospitality spending. The Dairy & Nutritionals segment benefits from structurally different commodity dynamics, with bulk cream pricing having been particularly favourable in FY26.

Risks and Uncertainties

The most material near-term risk for Noumi investors is the refinancing requirement for the Revolving Finance facility and convertible notes. Any difficulty in securing refinancing on acceptable terms could create material liquidity risk. The $67.2 million reported net loss — while largely non-cash — illustrates the ongoing complexity of Noumi's capital structure. The Investment in Plant-based Milks brand and marketing will only be justified if it translates into restored volume and EBITDA Margin in FY27 and beyond.

Catalysts to Watch

Resolution of the Revolving Finance facility and convertible note refinancing is the most critical near-term milestone for Noumi — clarity on this front would significantly reduce the financial overhang on the stock. Progress in FY27 on the Plant-based Milks EBITDA recovery — as the brand investment begins to generate returns — will be closely watched. Any announcement regarding the strategic direction of the business, including potential asset sales, partnerships, or Capital Structure changes, would also be market-moving.

Where Things Stand

Noumi is making consistent operating progress — revenue growth, improving EBITDA in both divisions, and a near-doubling of Dairy & Nutritionals earnings all demonstrate genuine underlying business improvement. The shadow over the investment case is the capital structure complexity and refinancing requirement. Investors who believe in the plant-based food growth story and the company's turnaround execution will be watching the refinancing outcome very closely.